Abstract
Fifty children with well-controlled seizures who were receiving carbamazepine (CBZ) monotherapy were tested on a battery of cognitive and motor tests. Time of CBZ was varied so that the children were tested both shortly after CBZ (when daily CBZ concentrations approached their peak) and before CBZ (when CBZ concentrations approached daily low or trough levels). Testing was blind so that the examiner was unaware of the time of CBZ or the child's type of seizure. Results showed only one group difference related to seizure type and no differences linked to overall CBZ concentration as measured in saliva. Peak and trough concentrations were associated with changes in several variables, however. The children performed significantly better shortly after CBZ (peak concentration day) on measures of seat activity, attention span, and motor steadiness, whereas response times appeared to be influenced in a task-specific manner.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
